کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
332540 | 545728 | 2007 | 6 صفحه PDF | دانلود رایگان |
![عکس صفحه اول مقاله: Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination](/preview/png/332540.png)
This study assessed the subjective and cardiovascular effects of relevant doses of cocaine administration during steady-state treatment of the combination of amantadine and baclofen compared to placebo. Participants included 8 healthy, male, cocaine-dependent, non-treatment-seeking individuals (age = 36.6 ± 5.9; 75% African American, 25% Caucasian; using cocaine for an average of 15.3 ± 6.5 years). Data were collected prior to and following double-blind intravenous administration of 0 mg, 20 mg, and 40 mg of cocaine. Data were collected at baseline, following 5 days of treatment with placebo, and again following 5 days of treatment with a combination of amantadine 100 mg t.i.d. and baclofen 30 mg t.i.d. counterbalanced for order of medication and placebo in a cross-over design. Results showed no significant alterations to cardiovascular variables (heart rate, systolic and diastolic blood pressure) from treatment using combination medication or placebo in the presence of cocaine. Self-rated “desire” for cocaine was significantly lower during cocaine administrations while participants were receiving treatment with amantadine–baclofen compared to infusions while taking placebo medication, although there was no difference in the intensity of cocaine-induced euphoria, or reduction in the likelihood to use cocaine if given access. Study findings support the safety of the amantadine–baclofen combination treatment for cocaine dependence.
Journal: Psychiatry Research - Volume 152, Issues 2–3, 30 August 2007, Pages 205–210